Management of Dyskinetic Cerebral Palsy
For dyskinetic cerebral palsy, implement a coordinated multidisciplinary care plan centered on intrathecal baclofen (ITB) or deep brain stimulation (DBS) for dystonia control, combined with early intensive rehabilitation, orthopedic surveillance, and aggressive management of gastrointestinal and respiratory complications to optimize function and prevent secondary impairments.
Core Treatment Algorithm
First-Line Dystonia Management
Start with intrathecal baclofen (ITB) as the primary intervention for reducing dystonia and spasticity in dyskinetic CP 1, 2. ITB demonstrates low to very low certainty evidence for improving dystonia, pain/comfort, ease of caregiving, and quality of life 1. The 2025 follow-up study showed that ITB successfully decreased both dystonia and spasticity in young adults with dyskinetic CP 2.
For patients with dystonia-predominant presentations who fail ITB or require additional intervention, deep brain stimulation (DBS) targeting the globus pallidus internus should be considered 1, 3. DBS shows efficacy for dystonia reduction, goal achievement, motor function improvement, and quality of life enhancement, with younger patients demonstrating greater improvement 1, 3.
Oral medications have limited evidence: Clonidine shows very low certainty evidence for improved dystonia and goal achievement 1. Trihexyphenidyl may be considered but evidence is weak. Notably, no direct evidence exists for oral baclofen, benzodiazepines, gabapentin, or medical cannabis in dyskinetic CP 1.
Rehabilitation Framework
Implement early diagnosis and intervention protocols using validated tools before age 2 years 4. After 5 months corrected age, combine MRI (86-89% sensitivity), Hammersmith Infant Neurological Examination (90% sensitivity), and Developmental Assessment of Young Children (83% C index) for accurate diagnosis 4.
Structure rehabilitation around:
- Motor performance enhancement through intensive physical therapy
- Occupational therapy for functional skills and adaptive equipment
- Speech therapy for communication (noting that 3 in 4 individuals with CP will talk) 4
- Cognitive enrichment programs (1 in 2 will have normal intelligence) 4
Prevention of Secondary Complications
Orthopedic surveillance is critical given the high risk of musculoskeletal problems (28% prevalence) 4. Monitor specifically for:
- Hip displacement: Implement structured follow-up programs with early intervention against muscle hypertonia and imbalance 5
- Scoliosis: Monitor closely, especially in ITB patients where progression may occur 3
- Joint contractures: The 2025 study identified severe ROM limitations in shoulder flexion/abduction/inward rotation, hip abduction, hamstrings, and knee extension 2
- Fractures: Reported in 40% of young adults with dyskinetic CP 2
Nutritional management is essential as 47% may develop underweight status and require gastrostomy 2. Address upper gastrointestinal problems proactively.
Respiratory complications are frequent in dyskinetic CP 2. Establish pulmonary surveillance protocols and aggressive management of respiratory infections.
Comorbidity Management
Address the high burden of associated conditions:
- Chronic pain (75% prevalence): Use multimodal pain management; ITB and DBS both show evidence for pain reduction 4, 1
- Epilepsy (35%): Standard antiepileptic protocols 4
- Sleep disorders (23%): Though interestingly, sleep problems were uncommon in the 2025 dyskinetic CP cohort 2
- Intellectual disability (49%): Cognitive support services 4
- Fatigue (64% in dyskinetic CP): Energy conservation strategies 2
Care Delivery Structure
Establish annual comprehensive interdisciplinary clinic visits lasting 3-4 hours where all specialists meet simultaneously with the family 6. This nurse-led model creates an Integrative Holistic Care Plan (IHCP) that:
- Eliminates fragmented care and conflicting recommendations
- Reduces duplication of services and healthcare costs
- Improves family satisfaction in access, communication, and coordination 6
- Provides a unified evidence-based care plan communicated to all providers 6
The team should include: developmental pediatrics, orthopedics, physical medicine and rehabilitation, physical therapy, occupational therapy, speech therapy, clinical nutrition, nursing, orthotics, and social work 6, 7.
Critical Pitfalls to Avoid
Do not delay ITB or DBS consideration in medically refractory cases—early intervention optimizes outcomes, particularly in younger patients 1, 3.
Monitor ITB patients for infection (a known complication) and potential scoliosis progression 3.
Recognize that dyskinetic CP differs from spastic quadriplegic CP: While motor impairments are severe, they are typically less severe than spastic quadriplegia, with different neuroimaging patterns (basal ganglia/thalamus lesions predominate) 8. However, 25% show normal neuroimaging or brain maldevelopment 8.
Address the psychosocial burden: Most adults with severe dyskinetic CP live with parents and face significant limitations in physical functioning, general health, and vitality 2. Early transition planning and family support are essential 7.
Botulinum neurotoxin has limited role in dyskinetic CP compared to spastic forms—it shows very low certainty evidence for goal achievement and caregiving ease but is not a primary dystonia treatment 1.
The evidence base remains limited (low to very low certainty for most interventions) 1, but the combination of ITB/DBS for movement disorder control, intensive rehabilitation, and proactive complication prevention represents the current standard of care for optimizing morbidity, mortality, and quality of life outcomes in this challenging population.